Genocea Biosciences Inc GNCAQ
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- — / —
- Shares Outstanding
- 58.78M
- Market Cap
- $58.78
- Volume/Avg
- 6,252 / 8,218
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Genocea Biosciences Inc is a USA-based biopharmaceutical company discovering and developing novel cancer immunotherapies using its proprietary ATLAS platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by next-generation sequencing of that patient's tumor. ATLAS zeroes in on both antigens that activate anti-tumor T cell responses and inhibitory antigens, or Inhibigens , that drive pro-tumor immune responses.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 74
- Website
- https://www.genocea.com
Valuation
Metric | GNCAQ |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | GNCAQ |
|---|---|
Quick Ratio | 1.12 |
Current Ratio | 1.35 |
Interest Coverage | −33.66 |
Quick Ratio
GNCAQ
Profitability
Metric | GNCAQ |
|---|---|
Return on Assets (Normalized) | −81.83% |
Return on Equity (Normalized) | −316.05% |
Return on Invested Capital (Normalized) | −148.28% |
Return on Assets
GNCAQ
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|cp^<<Z | LOCK|gNF%F | $138B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|$?C&>^ | LOCK|FT@q% | $98B | |||
| Moderna Inc MRNA | LOCK|j^@#&c# | LOCK|GB% | $94B | |||
| argenx SE ADR ARGX | LOCK|S&n%#$k | LOCK|J$w | $62B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|>b$Ph^K | LOCK|WvG | $50B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|M!$BkqL@ | LOCK|^#!r | $31B | |||
| Incyte Corp INCY | LOCK|c@m$^< | LOCK|x<^ | $25B | |||
| BioNTech SE ADR BNTX | LOCK|R!L@?<z | LOCK|TFF | $21B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|GS^%sc | LOCK|T$T% | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|@$Zs@@r | LOCK|FYw | $15B |
United States